Showing 481 - 500 of 571 results
Breaking the mould: Leadership announcement
Dr Ceri Brenner appointed new leader of the Centre for Accelerator Science
Meet some of the women from the history of ANSTO who were pioneers in their time
The celebration of the UN’s International Women’s Day 2023 has a theme that highlights the power of innovative IT to combat discrimination and the marginalisation of women globally.
Understanding how a common food additive causes changes in the microbiome
ANSTO has collaborated on a study assessing the impact of the commonly-used food additive titanium dioxide (TiO2) on gut microbiota and inflammation.
The characterisation of planetary materials
ANSTO provides a range of capabilities using neutrons, X-rays and infrared radiation to study the solids, liquids and gases that might be found in materials in our solar system and beyond.
The characterisation of planetary materials
ANSTO provides a range of capabilities using neutrons, X-rays and infrared radiation to study the solids, liquids and gases that might be found in materials in our solar system and beyond.
Applied Molecular Therapies launches its first theranostic product in prostate cancer treatment
Applied Molecular Therapies (AMT) has announced a successful TGA licence upgrade for the GMP manufacture of an emerging prostate cancer therapy, following the launch of a new joint venture between Cyclotek and ANSTO.
Improving the radiation tolerance of microelectronics for space
A team of Melbourne researchers and international partners from Italian Instituto Nazionale de Fisica Nucleare (INFN) and CERN, who are developing radiation-hardened semiconductor chips, used the unique state-of-art high energy ion microprobe on the SIRIUS ion accelerator at ANSTO’s Centre for Accelerator Science to test a prototype radiation-resistant computer chip
Determining the extent of soil erosion on a NSW vineyard
Research investigates low activation and low cost superconducting material for magnetic coils in next generation fusion reactors
Innovative cancer research
An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.
New global, first-of-a-kind ANSTO Synroc facility
A new nuclear medicine waste processing facility that showcases ANSTO Synroc technology is under construction.
Australian scientists helping end malaria
New beamline provides state-of-the-art imaging capability
The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.
Australia charges ahead with new Lithium Technology
Scientists at ANSTO together with Lithium Australia Limited (LIT) have developed a world-first technology to extract more lithium from lithium mining waste, in a game-changer for Australian lithium industry.
Surfing at the atomic scale: ANSTO scientists confirm experimentally new fundamental law for liquids
The first experimental evidence to validate a newly published universal law that provides insights into the complex energy states for liquids has been found using an advanced nuclear technique at ANSTO.
An accurate and inexpensive test for Malaria just around the corner
Synroc: Australian innovation increases technology readiness for waste treatment plant
Dharawal mural and sign unveiled
Dharawal Mural tells an ancient story. Aboriginal and Torres Strait Islander viewers are advised that webpage contains images of people who have died.
Infrared microspectroscopy
The Infrared Microspectroscopy beamline combines the high brilliance and collimation of the synchrotron beam through a Bruker V80v Fourier Transform Infrared (FTIR) spectrometer and into a Hyperion 3000 IR microscope to reach high signal-to-noise ratios at diffraction limited spatial resolutions between 3-8 μm.